Diabetic cardiac autonomic neuropathy: Omega-3 polyunsaturated fatty acids and heart rate variability

Main Article Content

Victoria Serhiyenko
Marta Hotsko
Ludmila Serhiyenko
Alexandr Serhiyenko


The aim of the study was to analyze the effect of ω-3 polyunsaturated fatty acids (ω-3 PUFAs) on the heart rate variability (HRV) parameters in patients with type 2 diabetes mellitus (T2DM) and advanced stage of cardiovascular autonomic neuropathy (CAN). We have examined 36 patients with T2DM and definite stage of CAN, aged between 50-59 years with disease duration 1-6 years and median glycated hemoglobin A1c 7.1%±0.12%. Patients were divided into 2 groups. The first group received traditional antihyperglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) received in addition 1 g/day of the ω-3 PUFAs for three months. Results. Prescription of the ω-3 PUFAs to the patients with T2DM and definite stage of СAN was accompanied by a statistically significant increase of the time-domain HRV parameters; the spectral HRV parameters during the active and passive periods compared to the control group. Conclusion. Obtained results suggest that the efficacy of ω-3 PUFAs is the result of a direct effect of the ω-3 PUFAs on the investigated indexes.

Article Details

How to Cite
Serhiyenko, V., Hotsko, M., Serhiyenko, L., & Serhiyenko, A. (2023). Diabetic cardiac autonomic neuropathy: Omega-3 polyunsaturated fatty acids and heart rate variability. Scientific Collection «InterConf+», (30(143), 360–367. https://doi.org/10.51582/interconf.19-20.02.2023.037


Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119. DOI: https://doi.org/10.1016/j.diabres.2021.109119

Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013 Jan;4(1):4-18. DOI: https://doi.org/10.1111/jdi.12042

Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R. et al.; Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011 Oct;27(7):639-53. DOI: https://doi.org/10.1002/dmrr.1239

Serhiyenko VA, Serhiyenko AA. Diabetic cardiac autonomic neuropathy. In: Saldaña J.R., ed. Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues. Basel: Springer, Cham. Springer Nature Switzerland AG. 2019, Section 53. 825-50. DOI: https://doi.org/10.1007/978-3-030-11815-0_53

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA. et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. DOI: https://doi.org/10.2337/dc16-2042

Silva-E-Oliveira J, Amélio PM, Abranches ILL, Damasceno DD, Furtado F. Heart rate variability based on risk stratification for type 2 diabetes mellitus. Einstein (Sao Paulo). 2017 Apr-Jun;15(2):141-7. DOI: https://doi.org/10.1590/s1679-45082017ao3888

Balcıoğlu AS, Müderrisoğlu H. Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015 Feb 15;6(1):80-91. DOI: https://doi.org/10.4239/wjd.v6.i1.80

Serhiyenko VA, Serhiyenko LM, Serhiyenko AA. Omega-3 polyunsaturated fatty acids in the treatment of diabetic cardiovascular autonomic neuropathy: A review. In: Moore SJ, ed. Omega-3: Dietary Sources, Biochemistry and Impact on Human Health. New York: Nova Science Publishers, 2017:79-154.

Adamec J, Adamec R. ECG Holter. Guide to Electrocardiographic Interpretation. New York; London: Springer Science & Business Media, 2008. p. 90. DOI: https://doi.org/10.1007/978-0-387-78187-7

Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015 Apr;1851(4):469-84. DOI: https://doi.org/10.1016/j.bbalip.2014.08.010

Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardiol. 2016 Jan;67(1):22-7. DOI: https://doi.org/10.1016/j.jjcc.2015.08.002

Christensen JH. Omega-3 polyunsaturated fatty acids and heart rate variability. In: Billman GE, ed. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: antiarrhythmic, proarrhythmic, both or neither? Lausanne CH: Frontiers Media SA, 2013:9-17. [13] Billman GE. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment. Pharmacol Ther. 2013 Oct;140(1):53-80. DOI: https://doi.org/10.1016/j.pharmthera.2013.05.011

Gao C, Liu Y, Gan Y, Bao W, Peng X, Xing Q. et al. Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials. Lipids Health Dis. 2020 May 8;19(1):87. DOI: https://doi.org/10.1186/s12944-020-01214-w